Patent ID: 11903907
Assignee: CATHAY GENERAL HOSPITAL
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  H | IPC A  H

Claim 0:
1. A method of antagonizing glycoprotein VI receptor, comprising administration of a therapeutically effective amount of the following compound of Formula (I) to a subject:, wherein
X is (CH2)1-6;
R1 is phosphate or carbonate;
R2 and R3 are each independently C2-6alkenyl, C1-10alkyl, —O—C1-10alkyl or —NH—C1-10alkyl, wherein the alkyl or alkenyl is unsubstituted or substituted; and
R4 and R5 are each independently one to three H, halogen, —OH, —NH2, NO2, C1-10alkyl, C2-6alkenyl, —O—C1-10alkyl or —NH—C1-10alkyl;
or a pharmaceutically acceptable salt thereof;
wherein the compound or a pharmaceutically acceptable salt thereof is administered by intravenous injection; and
wherein the compound or a pharmaceutically acceptable salt thereof is administered at a dose of about 0.01 to about 1.0 mg per kg body weight.